Omeros (OMER) Other Working Capital Changes (2012 - 2014)
Omeros (OMER) posted Other Working Capital Changes of $262000.0 for Q3 2014, little changed sequentially from $262000.0 in Q2 2014, and down 74.46% YoY from $1.0 million in Q3 2013.
Omeros (OMER) Other Working Capital Changes (2012 - 2014) Analysis & Trends
Omeros has reported Other Working Capital Changes for 3 years, with the latest figure at $262000.0 in Q3 2014.
- Quarterly Other Working Capital Changes fell 74.46% year-over-year to $262000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $1.8 million (down 40.93% YoY) and the FY2021 annual result came in at $668000.0, changed N/A from the prior year.
- Other Working Capital Changes steadied at $262000.0 in Q3 2014 per OMER's latest filing, from $262000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.1 million in Q1 2024 and troughed at -$7.0 million in Q2 2024.
- A 5-year average of $161823.5 and a median of $462000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 3703.85% in 2013, down 97.16% in 2013.
- Over 3 years, Other Working Capital Changes stood at $82000.0 in 2012, then jumped by 1151.22% to $1.0 million in 2013, then tumbled by 74.46% to $262000.0 in 2014.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $262000.0, $262000.0, and $263000.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 262,000.00 |
| Sep 30, 2014 | 262,000.00 |
| Sep 30, 2014 | 262,000.00 |
| Jun 30, 2014 | 262,000.00 |
| Jun 30, 2014 | 262,000.00 |
| Jun 30, 2014 | 262,000.00 |
| Mar 31, 2014 | 263,000.00 |
| Mar 31, 2014 | 263,000.00 |
| Mar 31, 2014 | 263,000.00 |
| Sep 30, 2013 | 1.03 Mn |
| Sep 30, 2013 | 1.03 Mn |
| Sep 30, 2013 | 1.03 Mn |
| Jun 30, 2013 | 1.87 Mn |
| Jun 30, 2013 | 1.87 Mn |
| Jun 30, 2013 | 1.87 Mn |
| Mar 31, 2013 | 87,000.00 |
| Mar 31, 2013 | 87,000.00 |
| Mar 31, 2013 | 87,000.00 |
| Sep 30, 2012 | 82,000.00 |
| Sep 30, 2012 | 82,000.00 |